Skip to main content

Clinical trial Epi-RCHOP

A Phase Ib-II Study of tazemetostat (EPZ-6438) in newly diagnosed Diffuse Large B Cell Lymphoma (DLBCL) or high risk Follicular Lymphoma (FL) patients treated by R-CHOP

Organ Non-Hodgkin lymphoma
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 1/2
Academic trial Non
Sponsor Lysarc
EudraCT Identifier 2016-001499-31
Inclusion criteria 1st line - DLBCL, transformed, follicular NHL grade IIIb
Last update